New Delhi: AstraZeneca has sent a legal notice to the Serum Institute regarding the delay in the supply of Covishield vaccine. Sources say that AstraZeneca has sent a legal notice to the Serum Institute of India for the delay in the supply of the Corona vaccine. Serum CEO Adar Poonawala said that the Indian government has banned Covishield ‘s large supply to other countries and it is difficult to explain India’s first claim to other countries. Covid vaccine is being sold at higher prices in those countries.
Poonawala has already said that there is already a lot of pressure on the current production capacity of Covishield . Poonawala said that the world needs vaccines and we are prioritizing India’s needs, but we are still facing a supply crisis. The Center said last week that there is no complete restriction on vaccine exports. . Poonawala said that the serum is preparing 6 to 6.5 crore vaccines every month. Till date, 10 crore Covishield vaccines have been exported to the Central Government and 6 crore vaccines have been exported.
At the same time, Covishield vaccine manufacturer Serum needs about 3000 crores to increase its production. Serum Institute of India (SII) CEO Adar Poonawala gave this information.
